2Weinreb N J, Andersson HC, Banikazemi M, et al. Prevalence of type 1 Gaucher disease in the United States [ J ]. Arch Intern Med, 2008, 168(3) : 326-328. 被引量：1
3Mistry PK, Cappellini MD, Lukina E, et al. A reappraisal of Gaucher disease-diagnosis and disease management algorithms[J]. AmJHematol, 2011, 86(1): 110-115. 被引量：1
4Pastores GM, Hughes DA. Gaucher Disease [ M/OL ]//Pagon RA, Adam MP, Amemiya A, et al. GeneReviews. Seattle:Roberta A Pagon,2000. 被引量：1
5Maas M, Poll LW, Terk MR. Imaging and quantifying skeletal involvement in Gaucher disease [ J ]. Br J Radiol, 2002, 75 Suppll : A13-A24. 被引量：1
6Wang RY, Bodamer OA, Watson MS, et al. Lysosomal storage diseases: diagnostic confirmation and management of presymptomafic individuals[J]. Genet Med, 2011, 13(5) : 457-484. 被引量：1
7Liao HC, Chiang CC, Niu DM, et al. Detecting multiple lysosomal storage diseases by tandem mass spectrometry - A national newborn screening program in Taiwan [ J ]. Clin Chim Acta, 2014, 431:80-86. 被引量：1
8Charrow J, Esplin JA, Gribble TJ, et al. Gaucher disease : recommendations on diagnosis, evaluation, and monitoring [ J]. Arch Intern Med, 1998, 158(16): 1754-1760. 被引量：1
9Park JK, Orvisky E, Tayebi N, et al. Myoclonic epilepsy in Gancher disease: genotype-phenotype insights from a rare patient subgroup[ J]. Pediatr Res, 2003, 53 (3): 387-395. 被引量：1
10Pastores GM, Weinreb N J, Aerts H, et al. Therapeutic goals in the treatment of Gaucher disease[ J]. Semin Hematol, 2004, 41 (4 Suppl 5) : 4-14. 被引量：1
